A holistic approach that has been around for over 50 years
A review of the development of Biomolecular vitorgan Therapy and modifications of Autohaemotherapy unavoidably highlights an unique personality: Karl Theurer, physician and scientist.
The vital question at the beginning of Biomolecular vitorgan Therapy was: "How can cell therapy be refined to produce a safe and therapeutically effective technique of –organ therapy in accordance with the principles of immunology and molecular biology? Theurer was obsessed by the thought that the success of the fresh cell implantation techniques practiced by Niehans must be due to the activity of molecular cell components. Theurer was also determined to dispel all the quite justified fears of allergic reactions and sensitization associated with cell therapy developing and immonologically flexible method of organ therapy.
After much theoretical work and numerous experiments, including tests on himself, Karl Theurer perfected a particularly conservative method of chemical preparation of organ substances by acid-vapourlysis of lyophilized organ powder in a vacuum. The method was patented. It was the key for the removal and reduction of species specificity while maintaining organ specificity and improving the solubility of cell components. That was the beginning of a perfectly safe and flexible therapeutic technique using biological molecules: Biomolecular vitorgan Therapy. Its inauguration provided a major stimulus to scientific research in organ immunology, allergology and molecular biology. There have been three main phases in the development of Biomolecular Vitorgan Therapy: first the convincing results obtained in practice confirmed the therapeutic therapy. In the second phase, objective data were obtained in veterinary medicine and basic research. The third and final phase is the scientific consolidation in clinics and practices.
Thanks are due to many therapists, scientists and clinicians whose commitment has enabled this aspect of molecular biology and immunology to assert itself in the face of much opposition, so that it now has an indisputable place in our catalogue of pharmaceutical resources.
Most diseases of man and animal are accompanied by particular morphological and molecular cell changes, some of which are so specific that it is actually impossible to reach a diagnosis from histological samples alone. Clinical chemistry also provides pointers to very specific cell defects. It seems a logical step to reverse these cell defects by supplying the body with the relevant components taken from healthy cells, so that the diseased organs can be function property again. This goes hand in hand with repair and renewal.
The therapeutic concept of providing sick organs with elements taken from identical healthy organ is not new. It can be traced back to the days of antiquity and also embraces Niehans’s cell therapy and organ lysate therapy.
Theurer initiated the principle of Biomolecular vitorgan Therapy in the early fifties. Theurer also was responsible for endowing this principle with immunological flexibility, thus making it absolutely safe. Theurer realized right from the strat that the therapeutic efficacy of organ preparations must be linked to their molecular components; proteins, peptides, lipids and polysaccharides. The nature of the internationally patented method of preparation, the holistic application, and the individual dose titration set this therapy apart from other organ extract and cell therapy techniques. Biomolecular vitorgan Therapy makes use of natural regulatory and metabolic substances which are similar in animals and man. Impaired regulatory processes are normalized by physiological means, providing causative support for the recovery process. The supporting experimental literature from leading university institutes and clinics all over the world is vast and there are countless report of success in human and veterinary practices.
It is precisely the causative effect which draws Biomolecular vitorgan Therapy so close to the philosophy of the naturopath. Its rule is not to concentrate on curing the symptoms, but to see the body as a whole and to treat it in its entirety. That is why this therapy does not use just one type of organ, e.g., thymus, which is, of course, very important, but also employs factors from other organs. Mono organ therapy with one factor only- cannot do justice to the principle of holistic medicine because path physiological processes are interwoven with the complexity of cybernetic principles. Using molecular extracts from healthy tissue for holistic therapy in accordance with immunological and allergy logical principle means “treating the cause, not just the symptoms” However, this book does not set out to deal specifically with the large volume of results and theories related to the principle of the method, it is aimed at the requirements of the practitioner. Details of the principles of Biomolecular Vitorgan Therapy and Modification of Autohaemotherapy (guidelines and reprints) can be obtained from Vitorgan Asia.